Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Adding menthol to topical creams for osteoarthritis provides significant pain relief

19.04.2004


Study demonstrates improved mobility, less pain, in patients with osteoarthritis



Osteoarthritis (OA) is a progressive, degenerative joint disease estimated to affect more than 21 million individuals in the United States. The Arthritis Foundation reports that arthritis is the leading disability of Americans resulting in over 39 million medical visits per year and $65 billion in medical expenses and lost wages. This condition is characterized by erosion of articular cartilage, caused by enzymatic and mechanical breakdown of the extracellular matrix. The most common symptoms are pain, stiffness, reduced joint range of motion, and limitations to normal activities of daily living such as getting up from a chair, walking, balance and strength, and ascending/descending stairs, as well as limitations to local muscular endurance and hand grip strength in patients with OA of the upper extremities.

Pain reducing medications such as acetaminophen, non-steroidal anti-inflammatory drugs (NSAIDs), and COX-2 inhibitors have been common treatments for osteoarthritis in the growing elderly population. However, these medications often have painful side effects or do not react well with other medications. Accordingly, there is a need for alternative treatments for the osteoarthritis patient.


One proven alternative treatment is the use of oral and/or a topical blend of cetylated fatty acids. Cetylated monounsaturated fatty acids have been shown to provide protection against arthritis in rats; a recent study demonstrated that a topical cream consisting of a blend of cetylated fatty acids significantly reduced pain and improved physical function in patients with knee osteoarthritis. In that study, the first treatment of the topical cream caused acute improvements in stair climbing ability, timed "up and go" performance, knee range of motion, and a reduction in pain within 30 minutes. Additional improvements were observed after 30 days of treatment. However, this research was for the topical cream in its developmental stage and was only used with patients with knee osteoarthritis.

A New Study

Recently, menthol has been added to this topical cream. Menthol has been shown to possess analgesic properties thereby reducing the sensation of pain. A new study extends previous research and examines the effects of a topical cream consisting of cetylated fatty acids, along with the addition of menthol, on pain and functional performance in patients with knee osteoarthritis over the course of one week. Additionally, several patients with elbow and wrist osteoarthritis were included to examine potential effects on upper-extremity performance and pain in these individuals.

The authors of "Treatment With A Cetylated Fatty Acid Topical Cream With Menthol Reduces Pain and Improves Functional Performance In Patients With Osteoarthritis," are Nicholas A. Ratamess, William J. Kraemer, Jeffrey A. Anderson, David P. Tiberio, Michael E. Joyce, Barry N. Messinger, Jeff S. Volek, Duncan N. French, Matthew J. Sharman, Ana L. Gómez, Barry A. Spiering, Jason D. Vescovi, Ricardo Silvestre, Carl M. Maresh, and Robert L. Hesslink Jr. The participating institutions were the Human Performance Laboratory, University of Connecticut, Storrs, CT; Department of Health and Exercise Science, The College of New Jersey, Ewing, NJ; and Imagenetix, Inc., San Diego, CA. The researchers will present their findings at the American Physiological Society’s (APS) (www.the-aps.org) annual scientific conference, Experimental Biology 2003, being held April 17-21, 2004, at the Washington, D.C. Convention Center.

Methodology

Twenty-eight patients (10 with knee OA, 10 with wrist OA, 8 with elbow OA) were assigned to an experimental group based upon the location of his/her diagnosed osteoarthritis (i.e., knee, elbow, or wrist). Each patient applied the cream to the affected area twice per day every day for one week and subsequently returned to the lab for post-study functional performance testing. Subjects were tested for pain, stiffness, knee range of motion (ROM), balance, and ability to rise from a chair, walk, and ascend/descend stairs for patients with knee osteoarthritis; patients with elbow and wrist osteoarthritis were tested for measures of grip strength, elbow ROM, muscular strength, local muscular endurance, and pain.

The significant improvements observed in the research team’s previous investigation with use of a topical cream consisting of a blend of cetylated fatty acids, coupled and the high test-retest reliability (R = 0.95 to 0.99), precluded the need for a control group for this study.

Results

Fifteen test results were obtained for patients with osteoarthritis of the knee, twelve for patients having OA in the elbow, and eight measurements were taken with patients diagnosed with wrist osteoarthritis. Across the board, the test measurements (available upon request) revealed that use of a cetylated fatty acid topical cream with the addition of menthol produced significant improvements in physical performance and reduced pain in patients with OA of the knee, wrist, and elbow.

Conclusions

Topical creams containing cetylated fatty acid are now being sold to consumers for the knee osteoarthritis. This study demonstrates that the addition of menthol adds a new pain relief component to the treatment and its effectiveness for osteoarthritis of the knee, elbow and wrist.


The American Physiological Society (APS) is America’s oldest biomedical sciences research society. The not-for-profit society, with some 11,000 members, is the publisher of 14 scientific journals, including the American Journal of Physiology, which has been published since 1898.

Donna Krupa | EurekAlert!
Further information:
http://www.the-aps.org/

More articles from Studies and Analyses:

nachricht Win-win strategies for climate and food security
02.10.2017 | International Institute for Applied Systems Analysis (IIASA)

nachricht The personality factor: How to foster the sharing of research data
06.09.2017 | ZBW – Leibniz-Informationszentrum Wirtschaft

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Terahertz spectroscopy goes nano

20.10.2017 | Information Technology

Strange but true: Turning a material upside down can sometimes make it softer

20.10.2017 | Materials Sciences

NRL clarifies valley polarization for electronic and optoelectronic technologies

20.10.2017 | Interdisciplinary Research

VideoLinks
B2B-VideoLinks
More VideoLinks >>>